ClinicalTrials.Veeva

Menu

TOnicity of Perioperative Maintenance SoluTions (TOPMAST-1)

N

Niels Van Regenmortel

Status and phase

Completed
Phase 4

Conditions

Water-Electrolyte Imbalance
Chloride Disorder
Fluid Retention
Potassium Disorders
Thoracic Diseases
Sodium Disorder
Fluid Overload

Treatments

Drug: Glucion 5%
Drug: NaCl 0.9% in Glucose 5% + 40mmol/L Potassium

Study type

Interventional

Funder types

Other

Identifiers

NCT03080831
17/4/34

Details and patient eligibility

About

Prospective randomized double blind phase IV trial studying the efficacy and safety of the tonicity of two different perioperative maintenance solutions: an isotonic solution containing NaCl 0.9 in glucose 5% with an added 40 mmol/L of potassium or a commercially available premixed solution (Glucion 5%) containing a.o. 54 mmol/L of sodium and 26 mmol/L of potassium. Both solutions are administered at 27 mL/kg of ideal body weight, as recommended by current guidelines (NICE 174) and both solutions are widely used in daily clinical practice. The primary hypothesis is that isotonic maintenance solutions lead to more fluid retention than hypotonic fluids. Metabolism of both solutions is assessed by sequential analysis of urine and serum and clinical parameters.

Enrollment

70 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult (at least 18 y.o.)
  • Undergoing elective lung resection (wedge resection, segmental resection, (bi)lobectomy, but not pneumonectomy) via thoracotomy or video- or robot assisted (VATS, RATS)
  • Normal renal function (eGFR >60 ml/min/1.73m² (CKD-EPI))

Exclusion criteria

  • Under chronic treatment with diuretics or desmopressin
  • Heart failure (NYHA III-IV)
  • Liver Failure
  • Brittle diabetes mellitus
  • Neurological contra-indication for hypotonic fluids
  • SIADH or hyponatremia <130 or > 150 mmol/L at preoperative assessment
  • Hyperkalemia > 5 mmol/L at preoperative assessment
  • Under treatment with artificial nutrition (enteral or parenteral)
  • Pregnancy

Additional pre-defined exclusion after initial inclusion

  • Massive perioperative transfusion or intraoperative resuscitation of +2.5L of crystalloids/colloids
  • Absence of admission to ICU

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

70 participants in 2 patient groups

NaCl 0.9% in Glucose 5% + 40mmol/L Potassium
Active Comparator group
Treatment:
Drug: NaCl 0.9% in Glucose 5% + 40mmol/L Potassium
Glucion 5%
Active Comparator group
Treatment:
Drug: Glucion 5%

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems